- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07642466
Adult Bladder and Quality of Life Evaluation in Spina Bifida (ABLE-SB)
Patient Reported Outcomes for Bladder Management Strategies in Young Adults With Spina Bifida
Přehled studie
Postavení
Detailní popis
Spina bifida is a congenital defect of the spine where some of the spinal cord and its covering (meninges) are exposed through a gap in the lower back or sacrum; this often results in paralysis of the lower limbs. The majority of spina bifida (SB) patients also have pelvic floor dysfunction (bladder, bowel, prolapse, sexual function) because of neurologic damage to this portion of the spinal nerves, and this increases the risk of their long-term morbidity.1 These problems place a substantial burden on patients' physical health and quality of life (QoL). Serious urological complications, such as urosepsis, skin breakdown, and renal failure, can occur in this patient population due to bladder dysfunction.2 Approximately 50% of young adults with SB have renal dysfunction3, 50% have urinary incontinence4, and they are nine times more likely to present with urinary tract infections5. The "gold standard" bladder management strategy when a person with SB is unable to void spontaneously is to perform clean intermittent catheterization (CIC). Alternatives to CIC include spontaneous voiding (if possible), incontinence products, an indwelling catheter (IDC), or reconstructive surgery (to create a urinary diversion or to enable CIC). However, IDC and surgery have increased risks of specific complications, including the risk of bladder cancer, urethral damage, urinary infections, and surgical morbidity.6 People with SB usually discuss bladder management options with their urologist, however they may prioritize a variety of factors around bladder management that directly affect their QOL, and these may not be as apparent to urologists. This is further complicated when patients reach adolescence and young adulthood; at this age they transition from pediatric to adult care providers, all while transitioning in other areas of their life (such as increasing responsibility, cognitive growth, and a wish for more independence). These factors may all impact thoughts about bladder management. Few studies have addressed QoL in relation to different bladder/bowel management methods in this SB age group, and most have not considered things like health literacy and cognitive function.
- Wiener JS, Suson KD, Castillo J, Routh JC, Tanaka ST, Liu T, Ward EA, Thibadeau JK, Joseph DB, Registry NSBP. Bladder Management and Continence Outcomes in Adults with Spina Bifida: Results from the National Spina Bifida Patient Registry, 2009 to 2015. The Journal of urology 2018;200:187-94.
- Nooten FE van, Winnette R, Stein R, Kissner M, Schröder A, Jöckel M, Raluy-Callado M, Lambrelli D, Meinhardt M, Wasiak R. Resource utilization and productivity loss in persons with spina bifida-an observational study of patients in a tertiary urology clinic in Germany. European journal of neurology : the official journal of the European Federation of Neurological Societies 2015;22:53-8.
- Malakounides G, Lee F, Murphy F, Boddy S-A. Single centre experience: long term outcomes in spina bifida patients. Journal of Pediatric Urology 2013;9:585-9.
- Verhoef M, Lurvink M, Barf HA, Post MWM, Asbeck FWA van, Gooskens RHJM, Prevo AJH. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord 2005;43:331-40.
- Tradewell M, Pariser JJ, Nimeh T, Elliott SP, Group NBR. Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida. Translational Andrology and Urology 2018;7:S205-19.
- Snow-Lisy DC, Yerkes EB, Cheng EY. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood. The Journal of urology 2015;194:288-96.
Typ studie
Zápis (Odhadovaný)
Kontakty a umístění
Studijní kontakt
- Jméno: Mary McKibbon, BNSc
- Telefonní číslo: 519-646-6367
- E-mail: mary.mckibbon@sjhc.london.on.ca
Studijní místa
-
-
Ontario
-
London, Ontario, Kanada
- Nábor
- St Joseph's Hospital
-
Kontakt:
- Mary McKibbon, BNSc
- Telefonní číslo: 5196466367
- E-mail: mary.mckibbon@sjhc.london.on.ca
-
Kontakt:
- Brenda Hodgins
- Telefonní číslo: 5196466000
- E-mail: brenda.hodgins@sjhc.london.on.ca
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Diagnosis of SB
- Age ≥13 years of age
- Able to effectively communicate in English or Spanish
- Willing to provide informed consent for participation and answer a set of questionnaires
Exclusion Criteria:
- Reconstructive surgery or urinary diversion in the last 3 months
- Hospital admission in the last 1 month
- Inconsistent or newly changed (within the last month) method of bladder management
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
|---|
|
Voiding/incontinence
SB patients who manage their bladder with voiding/incontinence
|
|
CIC
SB patients who manage their bladder with clean intermittent catheters
|
|
Diversion
SB patients who manage their urination with a surgical bladder diversion
|
|
Indwelling catheter
SB patients who manage their bladder with an indwelling catheter
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
QUALAS bladder and bowel quality of life domain
Časové okno: At the time of enrollment
|
The QUALAS is a validated quality of life measure for teens and adults with spina bifida.
It is scored from 0-100, with a higher score meaning better QOL
|
At the time of enrollment
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Blayne Welk, MD MSc, Western University
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 15140 (City of Hope Medical Center)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .